Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.

Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM, PROMINENT Investigators.

Open source

DOI: 10.1056/nejmoa2210645
Published: 2022-11-05
Container: N Engl J Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2210645,
  title = {Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.},
  author = {Das Pradhan A and  Glynn RJ and  Fruchart JC and  MacFadyen JG and  Zaharris ES and  Everett BM and  Campbell SE and  Oshima R and  Amarenco P and  Blom DJ and  Brinton EA and  Eckel RH and  Elam MB and  Felicio JS and  Ginsberg HN and  Goudev A and  Ishibashi S and  Joseph J and  Kodama T and  Koenig W and  Leiter LA and  Lorenzatti AJ and  Mankovsky B and  Marx N and  Nordestgaard BG and  Páll D and  Ray KK and  Santos RD and  Soran H and  Susekov A and  Tendera M and  Yokote K and  Paynter NP and  Buring JE and  Libby P and  Ridker PM and  PROMINENT Investigators.},
  year = {2022},
  journal = {N Engl J Med},
  doi = {10.1056/nejmoa2210645},
  url = {https://doi.org/10.1056/nejmoa2210645}
}

RIS

TY  - JOUR
TI  - Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
AU  - Das Pradhan A
AU  -  Glynn RJ
AU  -  Fruchart JC
AU  -  MacFadyen JG
AU  -  Zaharris ES
AU  -  Everett BM
AU  -  Campbell SE
AU  -  Oshima R
AU  -  Amarenco P
AU  -  Blom DJ
AU  -  Brinton EA
AU  -  Eckel RH
AU  -  Elam MB
AU  -  Felicio JS
AU  -  Ginsberg HN
AU  -  Goudev A
AU  -  Ishibashi S
AU  -  Joseph J
AU  -  Kodama T
AU  -  Koenig W
AU  -  Leiter LA
AU  -  Lorenzatti AJ
AU  -  Mankovsky B
AU  -  Marx N
AU  -  Nordestgaard BG
AU  -  Páll D
AU  -  Ray KK
AU  -  Santos RD
AU  -  Soran H
AU  -  Susekov A
AU  -  Tendera M
AU  -  Yokote K
AU  -  Paynter NP
AU  -  Buring JE
AU  -  Libby P
AU  -  Ridker PM
AU  -  PROMINENT Investigators.
PY  - 2022
JO  - N Engl J Med
DO  - 10.1056/nejmoa2210645
UR  - https://doi.org/10.1056/nejmoa2210645
ER  -

APA

A, D. P., RJ, G., JC, F., JG, M., ES, Z., BM, E., SE, C., R, O., P, A., DJ, B., EA, B., RH, E., MB, E., JS, F., HN, G., A, G., S, I., J, J., T, K., W, K., LA, L., AJ, L., B, M., N, M., BG, N., D, P., KK, R., RD, S., H, S., A, S., M, T., K, Y., NP, P., JE, B., P, L., PM, R., & Investigators., P. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.. N Engl J Med. https://doi.org/10.1056/nejmoa2210645

Source records

europe-pmc · retrieved 2026-09-25T04:28:35.187Z